![Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma | Journal of Clinical Oncology Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2003.11.136/asset/images/lj1430479002.jpeg)
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma | Journal of Clinical Oncology
![Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer | Journal of Clinical Oncology Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2007.15.0375/asset/images/zlj0190874760003.jpeg)
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
![The lung microenvironment: an important regulator of tumour growth and metastasis | Nature Reviews Cancer The lung microenvironment: an important regulator of tumour growth and metastasis | Nature Reviews Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41568-018-0081-9/MediaObjects/41568_2018_81_Fig1_HTML.png)